Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ$20.13
Market Cap
$359.58M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
809 of 924
Rank in Industry
458 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
RIGL Insider Trading Activity
RIGL Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $424,179 | 8 | 100 |
Related Transactions
| Furey Raymond J. | EVP, GC, CCO & Corp Sec | 0 | $0 | 2 | $59,653 | $-59,653 |
| Schorno Dean L | EVP & Chief Financial Officer | 0 | $0 | 2 | $80,615 | $-80,615 |
| Santos David A | EVP, Chief Commercial Officer | 0 | $0 | 2 | $83,836 | $-83,836 |
| RODRIGUEZ RAUL R | CEO, President | 0 | $0 | 2 | $200,075 | $-200,075 |
About Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the …
Insider Activity of Rigel Pharmaceuticals, Inc.
Over the last 12 months, insiders at Rigel Pharmaceuticals, Inc. have bought $0 and sold $424,179 worth of Rigel Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Rigel Pharmaceuticals, Inc. have bought $688,400 and sold $192,509 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000,000 shares for transaction amount of $688,400 was made by RODRIGUEZ RAUL R (CEO, President) on 2022‑06‑09.
List of Insider Buy and Sell Transactions, Rigel Pharmaceuticals, Inc.
| 2025-02-05 | Sale | RODRIGUEZ RAUL R | CEO, President | 4,400 0.0263% | $21.93 | $96,474 | -8.36% | |
| 2025-02-05 | Sale | Schorno Dean L | EVP & Chief Financial Officer | 1,734 0.0103% | $21.93 | $38,020 | -8.36% | |
| 2025-02-05 | Sale | Santos David A | EVP, Chief Commercial Officer | 1,796 0.0107% | $21.93 | $39,379 | -8.36% | |
| 2025-02-05 | Sale | Furey Raymond J. | EVP, GC, CCO & Corp Sec | 1,339 0.008% | $21.93 | $29,359 | -8.36% | |
| 2025-02-04 | Sale | RODRIGUEZ RAUL R | CEO, President | 4,952 0.0278% | $20.92 | $103,601 | +0.64% | |
| 2025-02-04 | Sale | Schorno Dean L | EVP & Chief Financial Officer | 2,036 0.0114% | $20.92 | $42,595 | +0.64% | |
| 2025-02-04 | Sale | Santos David A | EVP, Chief Commercial Officer | 2,125 0.0119% | $20.92 | $44,457 | +0.64% | |
| 2025-02-04 | Sale | Furey Raymond J. | EVP, GC, CCO & Corp Sec | 1,448 0.0081% | $20.92 | $30,294 | +0.64% | |
| 2024-02-05 | Sale | RODRIGUEZ RAUL R | CEO, President | 30,545 0.016% | $1.14 | $34,821 | +14.62% | |
| 2024-02-05 | Sale | Schorno Dean L | EVP & Chief Financial Officer | 7,027 0.0037% | $1.14 | $8,011 | +14.62% | |
| 2024-02-05 | Sale | Santos David A | EVP, Chief Commercial Officer | 8,918 0.0047% | $1.14 | $10,167 | +14.62% | |
| 2024-02-02 | Sale | RODRIGUEZ RAUL R | CEO, President | 22,349 0.0116% | $1.13 | $25,261 | +17.54% | |
| 2024-02-02 | Sale | Schorno Dean L | EVP & Chief Financial Officer | 5,601 0.0029% | $1.13 | $6,327 | +17.54% | |
| 2024-02-02 | Sale | Santos David A | EVP, Chief Commercial Officer | 5,601 0.0029% | $1.13 | $6,329 | +17.54% | |
| 2023-02-06 | Sale | RODRIGUEZ RAUL R | CEO, President | 20,340 0.012% | $1.75 | $35,595 | -26.90% | |
| 2023-02-02 | Sale | Schorno Dean L | EVP & Chief Financial Officer | 5,389 0.0029% | $1.66 | $8,946 | -28.81% | |
| 2023-02-02 | Sale | Santos David A | EVP, Chief Commercial Officer | 5,388 0.0029% | $1.66 | $8,945 | -28.81% | |
| 2023-02-02 | Sale | Dummer Wolfgang | EVP & CMO | 5,389 0.0029% | $1.66 | $8,946 | -28.81% | |
| 2022-06-09 | RODRIGUEZ RAUL R | CEO, President | 1M 0.5572% | $0.69 | $688,400 | +76.88% | ||
| 2019-05-22 | Schorno Dean L | EVP &Chief Financial Officer | 50,000 0.0311% | $2.13 | $106,544 | +2.44% |
Total: 215
*Gray background shows transactions not older than one year
Insider Historical Profitability
20.7%
| RODRIGUEZ RAUL R | CEO, President | 239454 1.3405% | $4.82M | 2 | 6 | +34.43% |
| Schorno Dean L | EVP & Chief Financial Officer | 57235 0.3204% | $1.15M | 1 | 5 | +2.44% |
| Flynn James E | 10 percent owner | 3204167 17.9375% | $64.5M | 1 | 1 | <0.0001% |
| BVF PARTNERS L P/IL | 10 percent owner | 646559 3.6195% | $13.02M | 1 | 1 | <0.0001% |
| Mayer Eldon C. III | EVP & Chief Commercial Officer | 215000 1.2036% | $4.33M | 3 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$5,911,307 | 70 | -1.38% | $309.77M | |
$109,415,500 | 33 | 18.13% | $353.41M | |
$41,446,394 | 27 | 12.91% | $340.18M | |
$14,865,077 | 18 | -28.56% | $389.16M | |
$276,750,010 | 16 | -7.95% | $385.21M |
RIGL Institutional Investors: Active Positions
| Increased Positions | 82 | +95.35% | 2M | +20.92% |
| Decreased Positions | 33 | -38.37% | 2M | -19.61% |
| New Positions | 39 | New | 980,892 | New |
| Sold Out Positions | 15 | Sold Out | 1M | Sold Out |
| Total Postitions | 135 | +56.98% | 12M | +1.31% |
RIGL Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $40,311.00 | 9.71% | 1.75M | +186,664 | +11.96% | 2024-12-31 |
| Morgan Stanley | $36,008.00 | 8.68% | 1.56M | +97,997 | +6.7% | 2024-12-31 |
| Armistice Capital, Llc | $26,565.00 | 6.4% | 1.15M | -384,000 | -25% | 2024-12-31 |
| Soleus Capital Management, L.P. | $26,073.00 | 6.28% | 1.13M | +195,891 | +20.96% | 2024-12-31 |
| Vanguard Group Inc | $23,358.00 | 5.63% | 1.01M | +27,640 | +2.81% | 2024-12-31 |
| Assenagon Asset Management S.A. | $9,473.00 | 2.28% | 410,778 | -30,987 | -7.01% | 2024-12-31 |
| Geode Capital Management, Llc | $9,271.00 | 2.23% | 402,051 | +2,388 | +0.6% | 2024-12-31 |
| State Street Corp | $8,775.00 | 2.11% | 380,515 | +12,720 | +3.46% | 2024-12-31 |
| Acadian Asset Management Llc | $8,679.00 | 2.09% | 376,366 | -45,414 | -10.77% | 2024-12-31 |
| Renaissance Technologies Llc | $6,911.00 | 1.67% | 299,709 | +157,763 | +111.14% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.